Subscribe to RSS - ResMed


ResMed to bring tech to bear on POC market


SAN DIEGO – ResMed plans to do for portable oxygen concentrators what it has done for CPAP machines. That is, make them connected devices that lower costs for HME providers and improve outcomes for patients.

Americas lead the way for ResMed


SAN DIEGO – ResMed reported revenues of $454.5 million for the three months ended Dec. 31, 2015, compared to $423 million for the same period in 2014, a 7% increase. It reported net income of $90.5 million vs. $91.2 million, a 1% decrease.

ResMed makes play for oxygen market

‘We see an excellent opportunity,’ says Jim Hollingshead

SAN DIEGO – Manufacturers of oxygen therapy devices will soon have a new competitor: ResMed.

ResMed becomes player in oxygen market


SAN DIEGO – ResMed has acquired Austin, Texas-based Inova Labs, adding oxygen concentrators to its portfolio of products aimed at treating patients with COPD.

ResMed’s Farrell sells $1M in shares


SAN DIEGO – Peter Farrell, founder and chairman of ResMed, sold 20,000 shares of company stock valued at $1.04 million in a transaction on Jan. 4. Farrell still owns 347,978 shares in the company, valued at $18.2 million.

The year's most read vendor stories

Wednesday, January 6, 2016

All eyes were on the big guns—Drive Medical, Invacare, Inogen and ResMed—in 2015.

Or so it would appear, according to the five most read vendor stories for the year.

Stock sellers: ResMed, Invacare


James Hollingshead, president of the Americas at ResMed, sold 4,500 shares of company stock on Dec. 15 in a transaction valued at $251,775. He sold the shares at an average price of $55.95.

Sleep therapy devices lead in remote monitoring, study says


GOTHENBURG, Sweden – Remote monitoring of patients with cardiac rhythm management devices and sleep therapy devices accounted for 81% of all connected home medical monitoring systems in 2015, according to a new study from Berg Insight.

ResMed Halifax gets rebate deal


HALIFAX, Nova Scotia – ResMed Halifax will earn a rebate of up to $787,500 over five years from the province of Halifax if it creates 40 new jobs, according to Nova Scotia Business.

In brief: Device maker buys Liberator, lawmakers seek complex rehab clarification


MURRAY HILL, N.J. – C.R. Bard, a manufacturer of medical devices for vascular, urology, oncology and surgical specialty fields, announced last week that it has acquired Liberator Medical for $181 million.